Francisco Aya

8PUBLICATIONS
25CO-AUTHORS
Predictive and prognostic markersTumour immunologyMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Dec 11, 2025
Personalized Circulating Tumor DNA Assay to Assess Long-Term Clinical Benefit in Patients with Advanced Melanoma.

Clara Martínez-Vila, Cristina Teixido, Roberto Martín

|Nov 19, 2025
Assessing brain metastasis response to immunotherapy: a pictorial review of atypical responses and intracranial adverse events.

Gary Amseian, Francisco Aya, Camilo Pineda

|Jan 25, 2025
Detection of Circulating Tumor DNA in Liquid Biopsy: Current Techniques and Potential Applications in Melanoma.

Clara Martínez-Vila, Cristina Teixido, Francisco Aya

|Sep 14, 2024
Lymphocyte T Subsets and Outcome of Immune Checkpoint Inhibitors in Melanoma Patients: An Oncologist's Perspective on Current Knowledge.

Clara Martínez-Vila, Europa Azucena González-Navarro, Cristina Teixido

|Jun 27, 2024
Predictive and Prognostic Factors in Melanoma Central Nervous System Metastases-A Cohort Study.

Estefania Serra, Álvaro Abarzua-Araya, Ana Arance

|Mar 10, 2022
Timeline of Adverse Events during Immune Checkpoint Inhibitors for Advanced Melanoma and Their Impacts on Survival.

Lorena Villa-Crespo, Sebastian Podlipnik, Natalia Anglada

Pageof 2

Frequent Collaborators

3 joint publications

Cristina Teixido

3 joint publications

Ana Arance

2 joint publications

Sebastian Podlipnik

2 joint publications

Cristina Carrera